These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2007-003766-17 Avastin-Injections in Age Related Macular Degeneration: Prospective Study for Optimal Frequency and Follow-up Determination 2013-05-27 due-trials
Completed, but no date, and reported results 2008-001974-33 mRNA-transfected dendritic cell vaccination in high risk uveal melanoma patients bad-data
Reported results 2008-008259-41 Anti-VEGF (bevacizumab/ranibizumab) versus RPE-choroid graft in the treatment of 1) non-responders to 3 intravitreal anti-VEGF injections, or 2) patients with AMD and pigment epithelium rip, or 3) pat... 2011-08-26 due-trials
Reported results 2009-009986-32 Continuation of platelet inhibiting drugs in eyelid surgery. A randomized, double-masked, placebo-controlled clinical trial. 2011-01-20 due-trials
Reported results 2009-017031-18 Treatment of Cystoid Macular Edema following cataract surgery. A randomized, double-masked, placebo-controlled, clinical trial. 2015-06-08 due-trials
Reported results 2009-017959-98 Early treatment of patients with central serous retinopathy: A randomized controlled trial 2018-07-04 due-trials
Reported results 2010-023636-17 Intravitreal versus submacular injection of rtPA for acute submacular haemorrhages. 2014-03-19 due-trials
Reported results 2010-024100-10 Clonidine as an adjuvant to prolong local anaesthesia in ophthalmic surgery with cryocoagulation. A randomized, controlled, patient-masked trial. 2013-05-03 due-trials
Reported results 2011-006066-40 The post-cataract inflammatory reaction with combination therapy of topical steroid and NSAID. 2014-12-31 due-trials
Ongoing 2012-003652-36 The Most Effective Treatment Strategy for Diabetic Macular Edema. not-yet-due
Ongoing 2012-005068-82 An alternative approach for treatment of infantile esotropia with botulinum toxin A. not-yet-due
Reported results 2014-000388-41 Does oral administration of dabigatran etexilate, a direct thrombin inhibitor, achieve clinical significant concentrations of dabigatran and thrombin inhibiting activity in vitreous and subretinal flu... 2015-04-22 due-trials
Reported results 2017-001158-33 A pilot study towards a therapy with prednisolone encapsulated liposomes for the treatment of Graves’ Orbitopathy with reduced systemic steroid exposure 2019-12-19 due-trials
Ongoing 2021-000265-33 Prospective study on safety and efficacy of gene therapy with voretigene neparvovec (Luxturna®) in patients with RPE65-associated inherited retinal degenerations not-yet-due